KalVista Pharma Terminates KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of HAE

RTTNews | hace 954
KalVista Pharma Terminates KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of HAE

(RTTNews) - KalVista Pharmaceuticals, Inc. (KALV) announced Monday that it has terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema (HAE).

This decision was based on the observation of liver enzyme (ALT/AST) elevations in multiple patients in all treatment groups of the trial. No patients had concomitant elevation of bilirubin levels and all were asymptomatic.

The KOMPLETE trial is a phase 2 clinical trial evaluating KVD824, an investigational oral plasma kallikrein inhibitor designed for the prevention of attacks in adults living with HAE.

Patients in the trial were randomized to one of three treatment groups, each placebo controlled: 300 mg, 600 mg, 900 mg KVD824 (or placebo), all dosed twice daily.

KalVista continues to recruit the phase 3 KONFIDENT trial assessing sebetralstat (formerly KVD900) as a potential oral, on-demand therapy for HAE attacks, with data anticipated in the second half of 2023.

For More Such Health News, visit rttnews.com

read more
KalVista Pharma Appoints Brian Piekos As New CFO

KalVista Pharma Appoints Brian Piekos As New CFO

KalVista Pharmaceuticals, Inc. (KALV) announced Tuesday that Brian Piekos has joined the Company as Chief Financial Officer (CFO). Piekos is an experienced public company CFO who brings a demonstrated track record of successfully leading companies across the biotechnology sector.
RTTNews | hace 248
European Shares Seen Flat To Higher At Open

European Shares Seen Flat To Higher At Open

European stocks are seen opening flat to slightly higher on Friday as investors look for the next trigger to move markets. A day after U.S. President Donald Trump announced that India has offered to "literally charge us no tariffs" on American goods, India's External Affairs Minister S Jaishankar labelled the talks "complicated' and warning "nothing is decided till everything is…"
RTTNews | hace 1h 14min
European Economic News Preview: Eurozone Foreign Trade Data Due

European Economic News Preview: Eurozone Foreign Trade Data Due

Foreign trade from the euro area and unemployment from France are due on Friday, headlining a light day for the European economic news. At 1.30 am ET, France's statistical office INSEE publishes unemployment data for the first quarter. The jobless rate is forecast to rise to 7.4 percent from 7.3 percent a quarter ago.
RTTNews | hace 1h 28min
Sensex, Nifty Modestly Lower On Weak Asian Cues

Sensex, Nifty Modestly Lower On Weak Asian Cues

Indian shares were a tad lower on Friday, tracking weak cues from other Asian markets. The benchmark S&P BSE Sensex was down 195 points, or 0.2 percent, at 82,333 in early trade while the broader NSE Nifty index dropped 47 points, or 0.2 percent, to 25,015.
RTTNews | hace 2h 19min
Australian Market Trims Early Strong Gains In Mid-market

Australian Market Trims Early Strong Gains In Mid-market

The Australian stock market is trimming its early strong gains in mid-market moves on Friday, adding to the gains in the previous seven sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving well above the 8,300 level, with gains across most sectors led by mining, financial and technology stocks.
RTTNews | hace 3h 7min
Asian Markets Trade Mostly Lower

Asian Markets Trade Mostly Lower

Asian stock markets are trading mostly lower on Friday, following the mixed cues from Wall Street overnight, as traders digested the latest settlements on the trade tariff front and remained caution as they awaited more clarity on the developments in trade negotiations with other trade partners. Asian markets ended mostly higher on Thursday.
RTTNews | hace 3h 22min
Sensex, Nifty Seen Higher At Open

Sensex, Nifty Seen Higher At Open

Indian shares are seen opening higher on Friday as India's foreign minister S Jaishankar said that trade talks with the U.S. are still going on and "nothing is decided till everything is".
RTTNews | hace 4h 12min
Thai Shares May Reclaim 1,200-Point Level

Thai Shares May Reclaim 1,200-Point Level

The Thai stock market has alternated between positive and negative finishes through the last seven trading days since the end of the five-day winning streak in which it had advanced more than 50 points or 4.3 percent. The Stock Exchange of Thailand now sits just beneath the 1,195-point plateau and it's expected to open to the upside on Friday.
RTTNews | hace 4h 46min